Synthetic Story of a Blockbuster Drug: Reboxetine, a Potent Selective Norepinephrine Reuptake Inhibitor | Organic Process Research & Development
Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors | PLOS Medicine
![Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients | Leukemia Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-022-01673-3/MediaObjects/41375_2022_1673_Fig1_HTML.png)
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients | Leukemia
![Anticoagulation in thrombocytopenic patients – Time to rethink? - Journal of Thrombosis and Haemostasis Anticoagulation in thrombocytopenic patients – Time to rethink? - Journal of Thrombosis and Haemostasis](https://www.jthjournal.org/cms/attachment/286786e1-1f4a-4d7d-981e-06e12c2e0742/jth15789-fig-0001-m_lrg.jpg)
Anticoagulation in thrombocytopenic patients – Time to rethink? - Journal of Thrombosis and Haemostasis
![Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation - ScienceDirect Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952920312222-grabsf1.jpg)
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation - ScienceDirect
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep - Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Mariasanta Napolitano, Melania Carlisi, Marta Mattana, Chiara Russo, Alessandro
![Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3 | bioRxiv Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3 | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2022/04/15/2022.04.14.488329/F2.large.jpg)
Regulation of inflammation and protection against invasive pneumococcal infection by the long pentraxin PTX3 | bioRxiv
![Frontiers | Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine Frontiers | Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine](https://www.frontiersin.org/files/Articles/1117815/fonc-13-1117815-HTML/image_m/fonc-13-1117815-g001.jpg)
Frontiers | Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine
![Barbui Porte di Barbui Maurizio e C. S.a.s. - Via Roma, 27 - 33095 San Giorgio Della Richinvelda (PN) Barbui Porte di Barbui Maurizio e C. S.a.s. - Via Roma, 27 - 33095 San Giorgio Della Richinvelda (PN)](https://static.pgol.it/responsive/img/staticmap.png?minCheck=3000&x=12.8715&y=46.049&xpix=400&ypix=224&z=0.9&sito=PB&fi=png&lg=NO&mi=NO&type=N)